LONDON, May 28, 2014 /PRNewswire/ --
The US markets saw a positive sentiment on Tuesday, May 27, 2014, with the NASDAQ Composite closing at 4,237.07, up 1.22%, the Dow Jones Industrial Average ending the session at 16,675.50, up 0.42% and the S&P 500 edging 0.60% higher to finish the trading session at 1,911.91. The gains were broad based as nine out of ten sectors ended the session in positive. A number of stocks saw large movements, including Aeropostale Inc. (NYSE: ARO), FirstEnergy Corp. (NYSE: FE), Cell Therapeutics Inc. (NASDAQ: CTIC) and Dyax Corp. (NASDAQ: DYAX). Free technical research on ARO, FE, CTIC and DYAX can be downloaded upon signing up at:
Aeropostale Inc.'s stock finished Tuesday's session 14.96% higher at $3.92. A total of 12.60 million shares were traded, which was above its three months average volume of 4.27 million shares. The stock moved between $3.66 and $3.98 during the session. Over the last one month and from the year's start, Aeropostale Inc.'s shares have lost 17.65% and 56.88%, respectively. The S&P 500 Consumer Discretionary Sector Index mapped a gain of 0.50% during the session, and it has advanced 2.98% in the last one month. The company's shares are trading below their 50-day and 200-day moving averages. Moreover, the stock's 200-day moving average of $7.80 is greater than its 50-day moving average of $4.89. On the same day, Aeropostale announced that it has entered into definitive agreements with respect to its previously announced strategic partnership and $150 million senior secured credit facilities with Sycamore Partners. Sign up today to read free research on ARO at:
On Tuesday, FirstEnergy Corp.'s stock fluctuated between $32.55 and $33.98 before ending the session 5.56% higher at $33.23. FirstEnergy Corp.'s stock reported a trading volume of 9.64 million shares, much above its three months average volume of 3.83 million shares. FirstEnergy Corp.'s shares have advanced 5.36% in the past three trading sessions and 7.92% in the last three months. Also, from the beginning of 2014, the company's stock has gained 0.76%. The S&P 500 Utilities Sector Index registered a gain of 0.82% during the session, while it has fallen by 2.77% in the last one month. The stock is trading above its 50-day moving average; whereas the 200-day moving average of $34.14 is above its 50-day moving average of $33.13. Moreover, shares of the company traded at a PE ratio of 12.14 and have a Relative Strength Index (RSI) of 35.78. Sign up today to read free research on FE at:
Shares in Cell Therapeutics Inc. surged 9.79% on Tuesday, closing the day at $3.14. The stock recorded a trading volume of 6.22 million shares, above its three months average volume of 3.85 million shares. The stock oscillated between $2.96 and $3.18 during the session. Over the past three trading sessions and last one month, shares in Cell Therapeutics Inc. have gained 23.62% and 3.63%, respectively. Also, the stock has rallied 64.40% since the start of this year. The S&P 500 Health Care Sector Index reported a gain of 0.56% during the trading session and it has advanced 1.15% in the past three trading sessions. The stock is trading above its 200-day moving average. Further, the stock's 50-day moving average of $3.17 is above its 200-day moving average of $2.42. Additionally, the stock has an RSI of 48.93. Sign up today to read free research on CTIC at:
On Tuesday, Dyax Corp.'s stock recorded a trading volume of 6.39 million shares, higher than its three months average volume of 1.75 million shares. The stock ended the day at $8.41, which was 27.42% above its previous day's closing price of $6.60. Further, the company's stock vacillated between $6.69 and $8.48 during the session. Dyax Corp.'s shares have gone up 34.13% in the past three trading sessions and 28.20% in the last one month. Also, the stock has surged 11.61% since the start of this year. The S&P 500 Health Care Sector Index mapped a gain of 0.56% during the session, and the index has advanced 3.21% in the last one month. The company's stock is trading above its 50-day and 200-day moving averages. The stock's 50-day moving average of $7.46 is above its 200-day moving average of $7.44. Furthermore, shares of the company have an RSI of 47.02. Sign up today to read free research on DYAX at:
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.